Fri, December 10, 2010
Thu, December 9, 2010
Wed, December 8, 2010
Tue, December 7, 2010
Mon, December 6, 2010
Fri, December 3, 2010
Thu, December 2, 2010
Wed, December 1, 2010
Tue, November 30, 2010
[ Tue, Nov 30th 2010 ] - Market Wire
2005 Certification
Mon, November 29, 2010
Thu, November 25, 2010
Wed, November 24, 2010
Tue, November 23, 2010
Mon, November 22, 2010
Sat, November 20, 2010
Fri, November 19, 2010
Thu, November 18, 2010
Wed, November 17, 2010
Tue, November 16, 2010

Gilead Sciences to Present at the NASDAQ OMX 25th Investor Program


//health-fitness.news-articles.net/content/2010/ .. ent-at-the-nasdaq-omx-25th-investor-program.html
Published in Health and Fitness on Tuesday, November 30th 2010 at 13:41 GMT by Market Wire   Print publication without navigation


FOSTER CITY, Calif.--([ BUSINESS WIRE ])--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that the company will be webcasting its corporate presentation at the NASDAQ OMX 25th Investor Program in London.

Kevin Young, Gileada™s Executive Vice President of Commercial Operations, will provide an overview of the company on Tuesday, December 7 at 10:15 a.m. Greenwich Mean Time (5:15 a.m. Eastern Standard Time).

To access the live webcast or a replay via the Internet log on to [ www.gilead.com ]. Please connect to the companya™s website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be necessary to listen to the webcast. The replay will be available for 14 days following the presentation.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The companya™s mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

For more information on Gilead Sciences, please visit [ www.gilead.com ] or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).


Publication Contributing Sources